Monsanto Company MON has carved a name for itself in the global agricultural chemicals’ industry. By conducting trade, the company tries to enhance the yield and quality of several commercial and non commercial agricultural crops such as cotton, soybean and corn.
However, the company’s trade is highly sensitive to market headwinds such as currency fluctuations and weather volatilities. Moreover, as the extent of industry competition increasing over time, investors have been eagerly awaiting for the company’s latest earnings report.
This is especially true given the recent earnings estimate revisions for MON, as the consensus estimate has moved down in the last few months.
Currently, MON has a Zacks Rank #4 (Sell), but that could definitely change after the release of its upcoming earnings report. We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: Monsanto reported adjusted earnings of $2.42 per share in second-quarter fiscal 2016, on an ongoing basis. The earnings was lower than the Zacks Consensus Estimate $2.45 per share.
Revenue: Monsanto posted revenues of $4,532 million, 5.1% lower than the Zacks Consensus Estimate of $4,776 million.
Key Stats to Note: Monsanto aims to improve its business on the back of its innovation based growth strategy. However, considering headwinds prevailing in the global and industrial markets, the company has lowered its full year ongoing earnings guidance to the range of $4.40-$5.10 per share from $5.10-$5.60. Free cash flow for fiscal 2016 is estimated to lie within $1.6-$1.8 billion, noting the benefits of disciplined cash management activities.
Stock Price: Shares prices of MON did not decreased on a pre-market trading basis.
Check back our full write up on this MON earnings report later!
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MONSANTO CO-NEW (MON): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research